Trial Profile
Dexmedetomidine Use During Therapeutic Hypothermia Treatment for Neonates With Hypoxic-ischemic Encephalopathy: The Cool DEX Study
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Encephalopathy
- Focus Pharmacokinetics
- Acronyms Cool DEX
- 10 Jan 2017 Status changed from not yet recruiting to completed.
- 24 Aug 2015 New trial record